Variable | Subvariable | All cases (n = 221) | ||
---|---|---|---|---|
 |  | HR | 95% CI | P-value |
Univariate | Â | Â | Â | Â |
Age | ≥47a yr (n = 103) vs. <47 yr (n = 117) | 1.654 | 0.931-2.938 | 0.086 |
Histology grade | I (n = 47) vs. IIIII (n = 174) | 7.696 | 1.871-31.651 | 0.005* |
Clinical stage | I II (n = 181) vs. III (n = 40) | 4.059 | 2.318-7.016 | <0.001* |
Tumor size stage | T1 (n = 63) vs. T2 + T3 (n = 158) | 2.799 | 1.260-6.219 | 0.011* |
Lymph nodes metastasis | absent (n = 105) vs. present (n = 116) | 3.361 | 1.759-6.422 | <0.001* |
Menopausal status | absent (n = 131) vs. present (n = 90) | 1.549 | 0.857-2.798 | 0.147 |
Rab27B expression | low (n = 107) vs. high (n = 114) | 8.661 | 3.897-19.251 | <0.001* |
ER status | absent (==97) vs. present (n = 124) | 0.588 | 0.339-1.022 | 0.06 |
PR status | absent (n = 91) vs. present (n = 130) | 0.505 | 0.291-0.878 | 0.015* |
CerbB2 status | 0, 1+, 2+ (n = 147) vs. 3+ (n = 74) | 1.504 | 0.861-2.628 | 0.152 |
Multivariate | Â | Â | ||
Histology grade | I (n = 47) vs. IIIII (n = 174) | 4.808 | 1.154-20.030 | 0.031* |
Tumour size | T1 (n = 63) vs. T2 + T3 (n = 158) | 2.630 | 1.167-5.924 | 0.020* |
Lynph nodes metastasis | absent (n = 105) vs. present (n = 116) | 2.696 | 1.398-5.197 | 0.003* |
Rab27B expression | low (n = 107) vs. high (n = 114) | 9.120 | 4.056-20.506 | <0.001* |
PR status | absent (n = 91) vs. present (n = 130) | 0.412 | 0.233-0.729 | 0.002* |